# Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

> **NCT02620787** · PHASE1 · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 18 (actual)

## Conditions studied

- Diabetes
- Wound Infection
- Healthy Volunteers

## Interventions

- **DRUG:** Tedizolid
- **PROCEDURE:** Microdialysis Catheter Insertion

## Key facts

- **NCT ID:** NCT02620787
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-23
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-03-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620787, "Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02620787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*